
Tesamorelin is a useful case study for the research-chemical vs prescription-pharmaceutical distinction, because unlike some research peptides, its active ingredient does have real pharmaceutical history elsewhere. That makes it especially important to be precise about what is, and isn't, the same product. Broadly, substances handled in the UAE fall into different regulatory buckets: licensed medicines that have completed formal drug registration and are marketed under an approved brand for a specific therapeutic indication; controlled or scheduled substances under narcotics legislation; and unscheduled research chemicals supplied for laboratory and research purposes, labelled as not for human consumption.
The research-grade Tesamorelin that REVIVE LAB UAE supplies sits in the third category — sold as an HPLC-verified research reference material, not as a registered medicine.
Tesamorelin's active ingredient has a documented pharmaceutical history: it has been approved in some markets under the brand name Egrifta as a prescription medicine for a specific indication, manufactured under pharmaceutical GMP standards, distributed through licensed pharmacy channels, and used under physician oversight. That is an entirely different product, supply chain, and regulatory channel from the research-grade Tesamorelin peptide sold by REVIVE LAB UAE for laboratory research.
REVIVE does not sell Egrifta, does not claim any equivalence to it, and does not make any therapeutic claims about the research material it supplies. The research-grade vial is a laboratory reagent — HPLC-verified for identity and purity, labelled research-use-only — not a substitute for, or version of, a licensed pharmaceutical product. Because REVIVE's Tesamorelin is not marketed or sold as a prescription drug in the UAE, it generally falls into the unscheduled research-chemical category rather than the pharmaceutical-registration category that would apply to a branded, prescribed product.
This is a general description of how the two channels differ conceptually — it is not a specific legal ruling about any individual shipment or use case. If you need certainty for your own circumstances, that should come from UAE customs, MOHAP, or a qualified lawyer, not from this article.
Separately from the classification question, anyone bringing any product into the UAE personally — pharmaceutical, cosmetic, supplement, or research chemical — is generally responsible for understanding the documentation, declarations, and permits their specific shipment may require, and for how customs treats that parcel on arrival. International personal shipments can be held for verification of contents, origin, and labelling, and the buyer typically carries that administrative load directly. This is a logistics reality that applies across product categories, not a comment on whether the underlying compound is permitted.
REVIVE LAB UAE holds Tesamorelin in stock domestically and ships from inside the UAE, so a purchase is a domestic transaction rather than an international parcel the buyer has to personally declare and clear. This removes the customs uncertainty, delay risk, and paperwork that comes with ordering research chemicals from overseas vendors directly — one of the practical reasons UAE research groups increasingly prefer sourcing locally.
REVIVE's Tesamorelin listings are deliberately scoped: research-use-only labelling on every vial, no therapeutic claims, no reference to Egrifta as an equivalent product, and no dosing or clinical-use guidance anywhere on the site. REVIVE does not claim MOHAP drug registration or any pharmaceutical marketing authorisation for this or any product — it operates strictly as a laboratory research-material supplier, and buyers are responsible for using the material in line with their own research context and applicable law.
| Spec | Detail |
|---|---|
| Form | Lyophilised powder, 10 mg vial |
| Molecular weight | ≈5135 Da |
| Purity (HPLC) | ≥98.5% |
| Class | GHRH analogue, 44 amino acids |
| Labelling | Research use only — not for human or veterinary use |
| Price | AED 629 per 10 mg vial |
Research-grade Tesamorelin supplied for laboratory and research purposes is generally classified as an unscheduled research chemical rather than a controlled substance in the UAE. This is general information, not legal advice — confirm specifics with UAE customs, MOHAP, or a qualified lawyer for your situation.
Tesamorelin's active ingredient has separate FDA-approved pharmaceutical history under the brand Egrifta for a specific indication in some markets — a different, separately regulated product and channel from the research-grade peptide REVIVE supplies.
Buying from a UAE-based supplier already holding domestic stock avoids the customs paperwork, delays, and interception risk of personal international shipments.
No. REVIVE does not claim MOHAP registration or any Egrifta-equivalent approval — it supplies HPLC-verified research material with clear non-human-consumption labelling.